Compounds > methotrexate
Page last updated: 2024-08-25

methotrexate and Central Nervous System Cysticercosis

methotrexate has been researched along with Central Nervous System Cysticercosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anand, P; Cho, TA; Gunaratne, S; Mukerji, SS; Thon, J; Venna, N1
Keiser, PB; Nash, TE1
Mitre, E; Nash, TE; Sperling, MR; Talaat, KR1

Other Studies

3 other study(ies) available for methotrexate and Central Nervous System Cysticercosis

ArticleYear
Steroid-sparing agents for the treatment of inflammation in complicated neurocysticercosis.
    Neurology(R) neuroimmunology & neuroinflammation, 2019, Volume: 6, Issue:6

    Topics: Adult; Female; Humans; Immunosuppressive Agents; Inflammation; Male; Methotrexate; Middle Aged; Neurocysticercosis

2019
Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, May-15, Volume: 36, Issue:10

    Topics: Adrenal Cortex Hormones; Albendazole; Animals; Anthelmintics; Edema; Humans; Male; Methotrexate; Middle Aged; Neurocysticercosis; Praziquantel; Taenia solium

2003
Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Feb-15, Volume: 44, Issue:4

    Topics: Adrenal Cortex Hormones; Adult; Cerebral Ventricles; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neurocysticercosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Subarachnoid Space; Treatment Outcome

2007